CVS Health

CVS Health
Name	CVS Health
Type	Public
Industry	Health care, Retail pharmacy
Founded	1963 (as Consumer Value Stores)
Headquarters	Woonsocket, Rhode Island, United States
Key people	Karen S. Lynch (President and CEO)
Revenue	US$322.5 billion (2023)
Num employees	300,000+

CVS Health CVS Health is a large American health care corporation operating retail pharmacy, pharmacy benefits management, and health services businesses. Founded in 1963 in Woonsocket, Rhode Island, the company expanded through acquisitions such as Caremark Rx, Aetna (company), and numerous regional drugstore chains, becoming integrated across retail, insurance, and clinical services. As a public company listed on the New York Stock Exchange, it has played a major role in U.S. health care markets, regulatory debates, and corporate consolidation.

History

The company began in 1963 as Consumer Value Stores in Woonsocket, Rhode Island, founded by brothers Stanley and Sidney Goldstein and partner Ralph Hoagland, later expanding through acquisitions of regional chains like Peoples Drug and Longs Drugs. In the 1990s and 2000s CVS pursued vertical integration, acquiring Caremark Rx in 2007 and growing its Pharmacy benefit management reach amid industry consolidation alongside peers such as Express Scripts and UnitedHealth Group. In 2014 CVS announced exit from tobacco sales and healthcare initiatives interacting with policy debates involving Food and Drug Administration and public health organizations like the Centers for Disease Control and Prevention. The acquisition of Aetna (company) in 2018 transformed the firm into an integrated payer-provider entity, drawing scrutiny from regulators including the United States Department of Justice and state attorneys general. Over subsequent years CVS expanded into telehealth, MinuteClinic services, and partnerships with technology firms such as Amazon (company) and payment systems interacting with Medicare and Medicaid programs.

Corporate structure and governance

The corporation is publicly traded under the ticker on the New York Stock Exchange and governed by a board of directors with executives including CEO Karen S. Lynch, succeeding predecessors like Larry Merlo and Tom Ryan. Its corporate governance interacts with federal regulators including the Securities and Exchange Commission and state insurance commissioners; activist investors and institutional shareholders such as The Vanguard Group and BlackRock influence strategic choices. The company organizes business units for retail pharmacies, CVS Caremark PBM operations, Aetna insurance lines, and health services like MinuteClinic, with executive leadership overseeing compliance with laws like the Employee Retirement Income Security Act of 1974 and regulations from agencies such as the Centers for Medicare & Medicaid Services.

Business operations and services

CVS operates thousands of retail locations and walk-in clinics such as MinuteClinic, dispensing prescriptions and offering immunizations tied to programs like Centers for Disease Control and Prevention vaccine recommendations and seasonal influenza campaigns. Its pharmacy benefit management arm, previously Caremark, negotiates drug formularies and rebates with pharmaceutical manufacturers including Pfizer, Merck & Co., and Johnson & Johnson, while administering benefits for employers and government programs like Medicare Part D. The Aetna acquisition integrated commercial and Medicare Advantage insurance products, competing with insurers such as UnitedHealth Group, Anthem, Inc., and Cigna. The company has developed digital health platforms, telemedicine partnerships, and specialty pharmacy services for biologics and oncology products from firms like Roche and Bristol Myers Squibb, while logistics and supply chain operations coordinate with distributors like McKesson Corporation and AmerisourceBergen.

Financial performance

As a large-cap public company, CVS reports revenues and earnings influenced by pharmacy dispensing volumes, insurance premiums, and PBM margins; key competitors include Walgreens Boots Alliance and Kroger's health initiatives. Financial filings to the Securities and Exchange Commission detail metrics such as operating cash flow, adjusted EBITDA, and segment performance for retail, pharmacy services, and health care benefits. Market reactions to strategic moves—like the Aetna acquisition—drew commentary from analysts at firms such as Goldman Sachs, Morgan Stanley, and J.P. Morgan Chase & Co., and credit ratings by agencies including Standard & Poor's and Moody's Investors Service affect borrowing costs for capital investments and store remodels. Shareholder returns reflect dividends and buybacks, with institutional ownership concentrated among major asset managers.

Legal issues and controversies

The company has faced litigation and regulatory scrutiny over opioid dispensing practices, paying settlements linked to lawsuits by state governments and counties such as those involving Ohio and Florida courts, alongside actions against distributors like McKesson Corporation. Antitrust concerns surrounded the Aetna merger, prompting review by the United States Department of Justice and state regulators; privacy and data handling issues intersect with laws such as the Health Insurance Portability and Accountability Act of 1996. Employment disputes, wage-and-hour claims, and class actions have been litigated in federal and state courts including venues in Rhode Island and California. Product liability and consumer protection cases—ranging from recall responses to pharmacy errors—have involved regulatory engagement with the Food and Drug Administration and state boards of pharmacy.

Corporate social responsibility and community impact

The company engages in public health initiatives including vaccination campaigns aligned with the Centers for Disease Control and Prevention and partnerships with community organizations such as the American Red Cross and local health departments. Its decision to cease tobacco sales invoked responses from public health advocates like the World Health Organization and sparked corporate responsibility discussions in academic venues such as Harvard T.H. Chan School of Public Health. Philanthropic efforts and community grants support programs addressing substance use disorder and chronic disease management in collaboration with nonprofits like March of Dimes and community health centers. Environmental and sustainability reporting references frameworks from organizations such as the Task Force on Climate-related Financial Disclosures while investor stewardship groups including Ceres and proxy advisory firms like Institutional Shareholder Services assess ESG performance.

Category:Healthcare companies of the United States Category:Retail companies established in 1963